Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
PennantPark Floating Rate Capital
PFLT
$698M
| $4.01M | ﹤0.01% |
388,070
-169,707
| -30% | -$1.72M |
|
4152
Oric Pharmaceuticals
ORIC
$1.17B
| $4.01M | ﹤0.01% |
394,785
+226,114
| +134% | +$1.52M |
|
|
CTEV
4153
Claritev Corp
CTEV
$399M
| $4.01M | ﹤0.01% |
88,776
+66,678
| +302% | +$1.92M |
|
4154
Lindblad Expeditions
LIND
$1.95B
| $4M | ﹤0.01% |
343,071
+50,941
| +17% | +$505K |
|
4155
Sigma Lithium
SGML
$1.05B
| $3.99M | ﹤0.01% |
886,263
+614,883
| +227% | +$4.06M |
|
4156
Playtika
PLTK
$1.53B
| $3.97M | ﹤0.01% |
839,473
+22,004
| +3% | +$108K |
|
4157
ClearPoint Neuro
CLPT
$424M
| $3.97M | ﹤0.01% |
332,323
+174,353
| +110% | +$2.19M |
|
4158
Village Super Market
VLGEA
$657M
| $3.97M | ﹤0.01% |
103,043
+2,846
| +3% | +$105K |
|
4159
Cass Information Systems
CASS
$716M
| $3.96M | ﹤0.01% |
91,119
+26,921
| +42% | +$1.12M |
|
4160
ProShares VIX Short-Term Futures ETF
VIXY
$221M
| $3.95M | ﹤0.01% |
84,349
+75,943
| +903% | +$4.37M |
|
4161
908 Devices
MASS
$312M
| $3.95M | ﹤0.01% |
554,245
+22,636
| +4% | +$126K |
|
4162
FlexShares iBoxx 5-Year Target Duration TIPS Index Fund
TDTF
$1.04B
| $3.94M | ﹤0.01% |
163,730
+3,541
| +2% | +$84.5K |
|
|
BULL
4163
Webull Corp
BULL
$3.73B
| $3.94M | ﹤0.01% |
+329,479
| New | +$5.1M |
|
|
SILA
4164
DELISTED
Sila Realty Trust
SILA
| $3.94M | ﹤0.01% |
166,289
+51,536
| +45% | +$1.3M |
|
|
HEAL
4165
Global X Funds Global X HealthTech ETF
HEAL
$28.8M
| $3.94M | ﹤0.01% |
120,250
+119,776
| +25,269% | +$3.62M |
|
4166
Bitdeer Technologies
BTDR
$2.17B
| $3.93M | ﹤0.01% |
342,355
+15,231
| +5% | +$176K |
|
4167
iShares iBonds 2028 Term High Yield and Income ETF
IBHH
$452M
| $3.93M | ﹤0.01% |
165,613
+67,391
| +69% | +$1.57M |
|
4168
Grove Collaborative
GROV
$45.8M
| $3.92M | ﹤0.01% |
3,412,178
+426,993
| +14% | +$505K |
|
|
NHS
4169
Neuberger High Yield Strategies Fund Inc
NHS
$250M
| $3.91M | ﹤0.01% |
516,020
+2,313
| +0.5% | +$17.3K |
|
4170
Cytek Biosciences
CTKB
$566M
| $3.91M | ﹤0.01% |
1,150,121
+404,644
| +54% | +$1.35M |
|
|
BRDG
4171
DELISTED
Bridge Investment Group
BRDG
| $3.91M | ﹤0.01% |
390,272
-22,161
| -5% | -$207K |
|
|
NUTX
4172
Nutex Health
NUTX
$967M
| $3.9M | ﹤0.01% |
31,308
+29,434
| +1,571% | +$3.8M |
|
4173
Trinity Capital Inc.
TRIN
$1.58B
| $3.9M | ﹤0.01% |
276,839
+90,849
| +49% | +$1.31M |
|
4174
Methode Electronics
MEI
$458M
| $3.89M | ﹤0.01% |
409,121
-89,025
| -18% | -$654K |
|
|
HPI
4175
John Hancock Preferred Income Fund
HPI
$428M
| $3.88M | ﹤0.01% |
242,878
-36,357
| -13% | -$576K |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.